Navigation Links
Drug innovation beats marketing, patents and mergers

In a recent BusinessWeek article profiling the significant rise in valuation of Genentech (NYSE: DNA), the authors point out that it is true product innovation through focused R&D efforts that's currently paying off in terms of investor confidence and resulting market valuation.

While Genentech had revenues of $4.6 bi......

Full article >>> r its two lead cancer drugs as well as other cancer drugs called Tarceva and Rituxan. Additional cancer drugs (such as Omnitarq in Phase II as well as another drug in Phase I) provide the company with one of the best cancer product portfolios.

The message here is that focused and productive R&D churning out innovative new drugs is currently winning the day over M&A, marketing and even sav......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 05/03/05


Related biology technology :

1. Changes to U.S. patent law must nurture our culture of innovation
2. Abbott vs. Thailand has implications for innovation and access
3. Visions: Benson touts embedded innovation
4. UW System must remove barriers to innovation
5. In western Wisconsin, the innovation economy is growing
6. Scott Converse, UW-Madison School of Business, on the innovation mind-set
7. New CEO at TDS on creating a culture of innovation (Part 2)
8. New CEO at TDS on tech innovation and leadership (Part 1)
9. Creativity, innovation extend to municipalities
10. Sir Ken Robinson: Companies, kids "get" innovation, but K-12 doesnt nurture it
11. TechnoJungle to highlight learning, innovation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):